Timothy J. Daskivich, MD, MSHPM is an Assistant Professor and the Director of Urologic Oncology in the Department of Urology at Cedars-Sinai Medical Center. He earned his MD from Harvard Medical School in 2006, completed his residency in Urology at UCLA in 2012 and did a combined health services research and urologic oncology fellowship with the Robert Wood Johnson Clinical Scholars Program and Institute of Urologic Oncology at UCLA.

Dr. Daskivich’s clinical practice includes comprehensive management of all genitourinary malignancies, including open, laparoscopic, and robotic approaches, with a focus on single and multiport robotic surgery and focal therapy for prostate cancer. His main research interests are longevity assessment and improving risk communication to optimize shared decision making in prostate cancer. He also conducts investigator-initiated trials involving prostate PET MRI imaging and using activity monitors to assess postoperative ambulation in men undergoing major surgery. He won the AUA/Urology Care Foundation Astellas Rising Stars in Urology Research award in 2018 for his NIH/NCI-funded K08 career development award, which involved development of a patient-centered approach to improve the quality of communication of prognosis and life expectancy to patients during prostate cancer treatment counseling discussions.